Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term randomized double-blind study of fluticasone furoate/GW642444 versus fluticasone furoate in asthma
2009-011461-84Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma comparing Fluticasone furoate/vilanterol once-daily with Fluticasone furoate once-daily (2 arms). Primary endpoint: Time to first severe asthma exacerbation. Started Jan 2010; status: completed.
02
Drugs
fluticasonevilanterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2009-011461-84.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011461-84.